STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDLN
  4. [Form 4] Medline Inc. Insider Trading Activity

Director Galanti awarded 5,387 RSUs at Medline (MDLN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GALANTI RICHARD A reported acquisition or exercise transactions in this Form 4 filing.

Medline Inc. director Richard A. Galanti reported stock-based compensation awards rather than open‑market purchases. He received 5,387 shares of Class A Common Stock as a grant at a price of $0.00 per share, bringing his direct holdings to 16,392 shares. Footnotes explain these are restricted stock units that vest either on March 30, 2027 or on the earlier of the first anniversary of grant and the next annual meeting of stockholders.

Positive

  • None.

Negative

  • None.
Insider GALANTI RICHARD A
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 5,387 $0.00 --
Grant/Award Class A Common Stock 11,005 $0.00 --
Holdings After Transaction: Class A Common Stock — 16,392 shares (Direct, null)
Footnotes (1)
  1. These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027. Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.
Latest RSU grant 5,387 shares Class A Common Stock grant on June 11, 2026
Prior RSU grant 11,005 shares Class A Common Stock grant on December 16, 2025
Price per share for grants $0.00 per share Both grants recorded as awards with no cash paid
Shares held after latest grant 16,392 shares Total direct Class A Common Stock holdings following June 11, 2026 award
RSU vesting date March 30, 2027 One RSU grant vests fully on this date
Alternative vesting trigger Earlier of first anniversary or next annual meeting Vesting condition for a separate RSU grant
restricted stock units ("RSUs") financial
"Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
initial public offering financial
"reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Registration Statement on Form S-1 regulatory
"as more fully described in the Registration Statement on Form S-1"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
annual meeting of stockholders financial
"vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GALANTI RICHARD A
(Last)(First)(Middle)
C/O MEDLINE INC.
3 LAKES DRIVE
(Street)
NORTHFIELD ILLINOIS 60093
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock12/16/2025A(1)11,005A(1)11,005D
Class A Common Stock06/11/2026A(2)5,387A$016,392D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027.
2. Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.
/s/ Nicole Fritz, Attorney-in-Fact06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Medline (MDLN) director Richard A. Galanti report in this Form 4?

Richard A. Galanti reported receiving a grant of 5,387 shares of Medline Class A Common Stock as stock-based compensation. The award was recorded at a price of $0.00 per share and increased his directly held position to a total of 16,392 shares.

Were Medline (MDLN) shares in this Form 4 bought on the open market?

No, the Medline shares were not bought on the open market. The filing shows two acquisitions coded as grants or awards (transaction code A), meaning they are compensation-related restricted stock unit grants at no cash cost to the director.

How many Medline (MDLN) shares does Richard A. Galanti hold after these transactions?

After the most recent reported grant, Richard A. Galanti directly holds 16,392 shares of Medline Class A Common Stock. This total reflects the latest award of 5,387 shares added to previously reported grants held under his direct ownership.

What vesting terms apply to the Medline (MDLN) RSU grants in this filing?

The filing notes restricted stock units that vest on March 30, 2027 and another grant that vests on the earlier of the first anniversary of the grant date or the next Medline annual stockholder meeting. Vesting schedules affect when the director fully receives the underlying shares.

What earlier Medline (MDLN) grant is referenced in Richard A. Galanti’s Form 4?

One footnote explains that certain securities were acquired in connection with a reclassification of Medline Holdings, LP interests before Medline’s initial public offering. These securities were previously reported on Galanti’s Form 3 filed on December 17, 2025 as restricted stock units.